PubRank

Joseph V Bonventre

Author PubWeight™ 279.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005 18.76
2 Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002 8.03
3 Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2009 7.34
4 Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008 6.54
5 Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010 4.76
6 Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005 4.10
7 Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2005 3.94
8 Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 2010 3.78
9 Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2003 3.61
10 Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 2008 3.59
11 Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007 3.48
12 Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 2008 3.10
13 Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 2010 3.07
14 Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011 3.05
15 Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J Clin Invest 2013 3.03
16 Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 2010 3.03
17 Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci 2008 2.98
18 Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009 2.96
19 Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 2006 2.75
20 Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int 2012 2.74
21 Acute renal failure in zebrafish: a novel system to study a complex disease. Am J Physiol Renal Physiol 2004 2.50
22 A rapid urine test for early detection of kidney injury. Kidney Int 2009 2.50
23 Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 2005 2.43
24 Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am J Pathol 2005 2.38
25 Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 2002 2.36
26 Mesenchymal stem cells in acute kidney injury. Annu Rev Med 2008 2.33
27 Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci U S A 2011 2.22
28 Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 2009 2.12
29 Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci 2008 2.09
30 Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. Am J Kidney Dis 2008 2.05
31 High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 2007 2.01
32 Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 2004 1.96
33 Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci 2007 1.94
34 Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum Mol Genet 2009 1.94
35 Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int 2009 1.94
36 Cytosolic phospholipase A2alpha is crucial [correction of A2alpha deficiency is crucial] for 'on-time' embryo implantation that directs subsequent development. Development 2002 1.91
37 Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol 2006 1.85
38 KIM-1-mediated phagocytosis reduces acute injury to the kidney. J Clin Invest 2015 1.80
39 Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol 2011 1.79
40 Protection of renal epithelial cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by ERK1/2 activation. J Biol Chem 2003 1.78
41 Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 2009 1.77
42 Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care 2004 1.75
43 Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J Biol Chem 2005 1.73
44 Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol 2005 1.71
45 Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. Kidney Int 2010 1.67
46 Kidney injury molecule-1 expression in murine polycystic kidney disease. Am J Physiol Renal Physiol 2002 1.64
47 Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003 1.63
48 Rapid screening of glomerular slit diaphragm integrity in larval zebrafish. Am J Physiol Renal Physiol 2007 1.63
49 Pathophysiology of acute kidney injury to chronic kidney disease: maladaptive repair. Contrib Nephrol 2011 1.57
50 Biomarkers of nephrotoxic acute kidney injury. Toxicology 2008 1.55
51 Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 2012 1.55
52 Immunolocalization of Kim-1, RPA-1, and RPA-2 in kidney of gentamicin-, mercury-, or chromium-treated rats: relationship to renal distributions of iNOS and nitrotyrosine. Toxicol Pathol 2008 1.51
53 T cell, Ig domain, mucin domain-2 gene-deficient mice reveal a novel mechanism for the regulation of Th2 immune responses and airway inflammation. J Immunol 2006 1.51
54 Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 2010 1.50
55 Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. Am J Physiol Renal Physiol 2006 1.47
56 NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2006 1.46
57 Urinary expression of novel tissue markers of kidney injury after ureteroscopy, shockwave lithotripsy, and in normal healthy controls. J Endourol 2013 1.46
58 Modulation of aquaporin-2/vasopressin2 receptor kidney expression and tubular injury after endotoxin (lipopolysaccharide) challenge. Crit Care Med 2008 1.44
59 Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 2001 1.43
60 Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant 2009 1.39
61 Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. Am J Physiol Renal Physiol 2006 1.36
62 Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice. Proc Natl Acad Sci U S A 2012 1.35
63 Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol 2011 1.35
64 Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway. Mol Neurodegener 2012 1.34
65 Systemic microvascular leak in an in vivo rat model of ventilator-induced lung injury. Am J Respir Crit Care Med 2003 1.32
66 The Sweet Pee model for Sglt2 mutation. J Am Soc Nephrol 2011 1.32
67 A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem Biophys Res Commun 2006 1.29
68 HIF in kidney disease and development. J Am Soc Nephrol 2008 1.28
69 Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem 2004 1.28
70 A framework and key research questions in AKI diagnosis and staging in different environments. Clin J Am Soc Nephrol 2008 1.27
71 Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2012 1.27
72 Deletion of secretory group V phospholipase A2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice. J Immunol 2007 1.25
73 Orchiectomy attenuates post-ischemic oxidative stress and ischemia/reperfusion injury in mice. A role for manganese superoxide dismutase. J Biol Chem 2006 1.25
74 Mechanistic biomarkers for cytotoxic acute kidney injury. Expert Opin Drug Metab Toxicol 2006 1.24
75 Stretch-induced IL-8 depends on c-Jun NH2-terminal and nuclear factor-kappaB-inducing kinases. Am J Physiol Lung Cell Mol Physiol 2003 1.24
76 Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma. Am J Surg Pathol 2007 1.22
77 Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat Biotechnol 2015 1.21
78 Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J Biol Chem 2006 1.20
79 Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicol Sci 2009 1.18
80 Brain lipid metabolism in the cPLA2 knockout mouse. J Lipid Res 2003 1.18
81 Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region. J Am Soc Nephrol 2007 1.17
82 Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2. Carcinogenesis 2004 1.16
83 Cross-talk between cytosolic phospholipase A2 alpha (cPLA2 alpha) and secretory phospholipase A2 (sPLA2) in hydrogen peroxide-induced arachidonic acid release in murine mesangial cells: sPLA2 regulates cPLA2 alpha activity that is responsible for arachidonic acid release. J Biol Chem 2003 1.16
84 Dialysis in acute kidney injury--more is not better. N Engl J Med 2008 1.15
85 Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. J Am Soc Nephrol 2013 1.14
86 Biomarkers for the diagnosis of acute kidney injury. Curr Opin Nephrol Hypertens 2007 1.14
87 Signaling via macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of Rac activity. J Biol Chem 2011 1.13
88 Human group V phospholipase A2 induces group IVA phospholipase A2-independent cysteinyl leukotriene synthesis in human eosinophils. J Biol Chem 2003 1.13
89 Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2. J Biol Chem 2003 1.11
90 Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy. EMBO J 2002 1.11
91 Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time. Am J Physiol Renal Physiol 2009 1.11
92 Animal models of acute tubular necrosis. Curr Opin Crit Care 2002 1.11
93 Ceramide 1-phosphate is required for the translocation of group IVA cytosolic phospholipase A2 and prostaglandin synthesis. J Biol Chem 2009 1.10
94 Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol 2009 1.10
95 Onconephrology: the latest frontier in the war against kidney disease. J Am Soc Nephrol 2012 1.10
96 Orchiectomy reduces susceptibility to renal ischemic injury: a role for heat shock proteins. Biochem Biophys Res Commun 2005 1.09
97 The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair. FASEB J 2010 1.09
98 Imaging of podocyte foot processes by fluorescence microscopy. J Am Soc Nephrol 2012 1.08
99 Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases. Am J Surg Pathol 2011 1.07
100 Training PhD researchers to translate science to clinical medicine: closing the gap from the other side. Nat Med 2002 1.07
101 The contribution of adult stem cells to renal repair. Nephrol Ther 2007 1.06
102 M1 muscarinic receptors inhibit L-type Ca2+ current and M-current by divergent signal transduction cascades. J Neurosci 2006 1.06
103 Deletion of cytosolic phospholipase A2 promotes striated muscle growth. Nat Med 2003 1.05
104 Cytosolic phospholipase A(2) in hypoxic pulmonary vasoconstriction. J Clin Invest 2002 1.04
105 Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study. PLoS One 2012 1.04
106 Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity. Proc Natl Acad Sci U S A 2012 1.03
107 Pathways regulating cytosolic phospholipase A2 activation and eicosanoid production in macrophages by Candida albicans. J Biol Chem 2010 1.02
108 Role of cytosolic phospholipase A(2) in prostaglandin E(2) production by lung fibroblasts. Am J Respir Cell Mol Biol 2003 1.01
109 Biomarkers for the diagnosis of acute kidney injury. Nephron Clin Pract 2008 1.01
110 Cytosolic phospholipase A2alpha regulates induction of brain cyclooxygenase-2 in a mouse model of inflammation. Am J Physiol Regul Integr Comp Physiol 2005 1.00
111 Function, activity, and membrane targeting of cytosolic phospholipase A(2)zeta in mouse lung fibroblasts. J Biol Chem 2007 0.99
112 Renal ischemia/reperfusion and ATP depletion/repletion in LLC-PK(1) cells result in phosphorylation of FKHR and FKHRL1. Kidney Int 2003 0.99
113 Group V secretory PLA2 regulates TLR2-dependent eicosanoid generation in mouse mast cells through amplification of ERK and cPLA2alpha activation. Blood 2007 0.98
114 The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity. Toxicol Sci 2007 0.97
115 Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia 2014 0.97
116 Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. Toxicol Appl Pharmacol 2009 0.97
117 Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis. Cancer Res 2005 0.96
118 Kim-1/Tim-1 and immune cells: shifting sands. Kidney Int 2012 0.96
119 Novel assays for detection of urinary KIM-1 in mouse models of kidney injury. Toxicol Sci 2012 0.95
120 Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma. Am J Surg Pathol 2015 0.94
121 Annexin A6-induced inhibition of cytoplasmic phospholipase A2 is linked to caveolin-1 export from the Golgi. J Biol Chem 2008 0.94
122 The CtBP2 co-repressor is regulated by NADH-dependent dimerization and possesses a novel N-terminal repression domain. Nucleic Acids Res 2004 0.94
123 Performance of novel kidney biomarkers in preclinical toxicity studies. Toxicol Sci 2010 0.93
124 Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells. Am J Physiol Renal Physiol 2004 0.93
125 High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline. Semin Nephrol 2012 0.93
126 Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity. Biochem Pharmacol 2013 0.90
127 Role of cytosolic NADP+-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2008 0.90
128 Elevated urinary levels of kidney injury molecule-1 among Chinese factory workers exposed to trichloroethylene. Carcinogenesis 2012 0.89
129 Limb ischemia protects against contrast-induced nephropathy. Circulation 2012 0.89
130 Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens 2005 0.88
131 P53 mediates ceramide-induced apoptosis in SKN-SH cells. Oncogene 2002 0.88
132 Towards the application of proteomics in renal disease diagnosis. Clin Sci (Lond) 2005 0.88
133 Preclinical evaluation of novel urinary biomarkers of cadmium nephrotoxicity. Toxicol Appl Pharmacol 2009 0.87
134 Cytosolic phospholipase a2 activation by Candida albicans in alveolar macrophages: role of dectin-1. Am J Respir Cell Mol Biol 2009 0.87
135 Attenuation of the pulmonary inflammatory response following butylated hydroxytoluene treatment of cytosolic phospholipase A2 null mice. Am J Physiol Lung Cell Mol Physiol 2006 0.87
136 Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children. Biomark Med 2014 0.87
137 Omi/HtrA2 protease is associated with tubular cell apoptosis and fibrosis induced by unilateral ureteral obstruction. Am J Physiol Renal Physiol 2010 0.86
138 Activation of cytosolic phospholipase A2alpha in resident peritoneal macrophages by Listeria monocytogenes involves listeriolysin O and TLR2. J Biol Chem 2007 0.86
139 Microvesicles from mesenchymal stromal cells protect against acute kidney injury. J Am Soc Nephrol 2009 0.85
140 Methylmercury-induced toxicity is mediated by enhanced intracellular calcium through activation of phosphatidylcholine-specific phospholipase C. Toxicol Appl Pharmacol 2006 0.85
141 Meaningful measurement: developing a measurement system to improve blood pressure control in patients with chronic kidney disease. J Am Med Inform Assoc 2013 0.85
142 Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease. Am J Nephrol 2012 0.85
143 Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes. Kidney Int 2016 0.85
144 Cytosolic phospholipase A(2)α and eicosanoids regulate expression of genes in macrophages involved in host defense and inflammation. PLoS One 2013 0.85
145 Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine? Pediatr Nephrol 2014 0.84
146 Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death. J Neurochem 2008 0.84
147 TIM2 gene deletion results in susceptibility to cisplatin-induced kidney toxicity. Toxicol Sci 2010 0.84
148 TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability. Cell Cycle 2004 0.84
149 Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury. Ann Neurol 2014 0.84
150 Polymorphism of host response genes: implications in the pathogenesis and treatment of acute renal failure. Kidney Int 2005 0.83
151 Daily hemodialysis--will treatment each day improve the outcome in patients with acute renal failure? N Engl J Med 2002 0.83
152 Impact of Cyclin B2 and Cell division cycle 2 on tubular hyperplasia in progressive chronic renal failure rats. Am J Physiol Renal Physiol 2010 0.83
153 Serine hydrolase inhibitors block necrotic cell death by preventing calcium overload of the mitochondria and permeability transition pore formation. J Biol Chem 2013 0.82
154 Differences in immunolocalization of Kim-1, RPA-1, and RPA-2 in kidneys of gentamicin-, cisplatin-, and valproic acid-treated rats: potential role of iNOS and nitrotyrosine. Toxicol Pathol 2009 0.81
155 cPLA2-interacting protein, PLIP, causes apoptosis and decreases G1 phase in mesangial cells. Am J Physiol Renal Physiol 2005 0.81
156 Secreted factors from bone marrow stromal cells upregulate IL-10 and reverse acute kidney injury. Stem Cells Int 2012 0.81
157 Cytosolic phospholipase A(2)α protects against ischemia/reperfusion injury in the heart. Clin Transl Sci 2011 0.80
158 Tumor necrosis factor alpha promoter polymorphism and severity of acute kidney injury. Nephron Clin Pract 2013 0.80
159 TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors. J Transl Med 2009 0.79
160 Focal adhesion kinase signaling mediates acute renal injury induced by ischemia/reperfusion. Am J Pathol 2011 0.79
161 Group IVA phospholipase A₂ optimizes ovulation and fertilization in rodents through induction of and metabolic coupling with prostaglandin endoperoxide synthase 2. FASEB J 2012 0.79
162 Participation of cytosolic phospholipase A2 in eicosanoid generation by mouse bone marrow-derived mast cells. Adv Exp Med Biol 2002 0.79
163 Can we rely on blood urea nitrogen as a biomarker to determine when to initiate dialysis? Clin J Am Soc Nephrol 2006 0.79
164 Kidney tubules: intertubular, vascular, and glomerular cross-talk. Curr Opin Nephrol Hypertens 2016 0.78
165 Identification of PP2A as a novel interactor and regulator of TRIP-Br1. Cell Signal 2008 0.78
166 Regenerating the nephron with human pluripotent stem cells. Curr Opin Organ Transplant 2015 0.78
167 Novel non-rodent models of kidney disease. Curr Mol Med 2005 0.78
168 High risk of ESRD in type 1 diabetes: call for action: introduction. Semin Nephrol 2012 0.77
169 Antifibrotic vitamin D analogs. J Clin Invest 2013 0.77
170 Transplanting cloned cells into therapeutic promise. Nat Biotechnol 2002 0.77
171 Renoprotective mechanisms of soy protein intake in the obese Zucker rat. Am J Physiol Renal Physiol 2008 0.77
172 Group IVA phospholipase A2 regulates testosterone biosynthesis by murine Leydig cells and is required for timely sexual maturation. Biochem J 2011 0.77
173 Imperfect gold standards for biomarker evaluation. Clin Trials 2013 0.76
174 Purification and characterization of a cytosolic Ca(2+)-independent phospholipase A(2) from bovine brain. Mol Cells 2011 0.75
175 Evaluation of putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 in germ cell tumors: a tissue microarray study of 100 cases. Appl Immunohistochem Mol Morphol 2012 0.75
176 The kidney proteome: a hint of things to come. Kidney Int 2002 0.75
177 Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma. Int Urol Nephrol 2013 0.75
178 Use of postoperative creatinine to predict sustained kidney injury in patients undergoing mesothelioma surgery. Clin J Am Soc Nephrol 2012 0.75
179 Multipotent mesenchymal stromal cells protect against kidney injury. Cytotherapy 2013 0.75
180 Biomarkers in translation; past, present and future. Toxicology 2007 0.75
181 Academic interventional nephrology: a model for training, research, and patient care. Clin J Am Soc Nephrol 2012 0.75
182 Dose of dialysis in acute renal failure. Semin Dial 2004 0.75